Obesity Does Not Influence Outcomes in XXXX @entity1 following Curative Hepatectomy.

@entity1 @entity28 @entity5 @entity5906 @entity260 @entity157
BACKGROUND: Whether @entity28 affects surgical outcomes in @entity1 with @entity157 ( @entity157 ) is controversial. Here we retrospectively evaluated the impact of @entity28 on outcomes in @entity157 @entity1 after curative hepatectomy. METHODS: @entity1 with @entity1 -Pugh A liver function who underwent curative hepatectomy between 2006 and 2010 were categorized as @entity28 (BMI >= 25 kg/m2, n = 68) and @entity28 (<25 kg/m2, n = 242). To reduce interference from baseline differences between the two groups, propensity score-matched analysis was performed in the ratio 1:2 using a caliper width of 0.1. Surgical outcomes were compared for 61 @entity28 and 115 @entity28 @entity1 . RESULTS: @entity28 @entity1 had higher levels of albumin and @entity5906 aminotransferase, and more @entity5 compared to the @entity28 @entity1 (all P<0.05). In the propensity-matched cohort, baseline characteristics did not differ between the two groups (all P>0.05). @entity28 and @entity28 @entity1 had comparable 30-day mortality (1.6% vs. 2.6%, P = 1.000), 90-day mortality (3.3% vs. 4.3%, P = 1.000), and incidence of @entity260 (19.7% vs. 18.3%, P = 0.819). Overall survival at 1, 3, and 5 years was similar for @entity28 @entity1 (83.6%, 63.6%, 41.6%) as for @entity28 @entity1 (80.9%, 65.9%, 49.1%; P = 0.358). Disease-free survival at 1, 3, and 5 years was also similar for @entity28 @entity1 (71.5%, 36.3%, 24.3%) as for @entity28 ones (60.2%, 43.7%, 27.7%; P = 0.969). CONCLUSION: Our propensity score-matched analysis strengthens the case that @entity28 does not adversely affect surgical outcomes of @entity157 @entity1 undergoing curative hepatectomy.
